Resveratrol prevents ovariectomy-induced bone quality deterioration by improving the microarchitectural and biophysicochemical properties of bone

[1]  Yongguang Gao,et al.  The Development of Molecular Biology of Osteoporosis , 2021, International journal of molecular sciences.

[2]  X. S. Liu,et al.  Peak Trabecular Bone Microstructure Predicts Rate of Estrogen-Deficiency-Induced Bone Loss in Rats. , 2021, Bone.

[3]  J. Nyman,et al.  Compositional assessment of bone by Raman spectroscopy. , 2021, The Analyst.

[4]  H. Yoshioka,et al.  Active sites of human MEPE-ASARM regulating bone matrix mineralization , 2020, Molecular and Cellular Endocrinology.

[5]  M. Frings-Dresen,et al.  Work ability and percentage of hours worked related to limitations in patients with upper extremity musculoskeletal disorders: a cross-sectional cohort study , 2020, BMC Musculoskeletal Disorders.

[6]  Xiaomeng You,et al.  Resveratrol promotes osteogenesis and alleviates osteoporosis by inhibiting p53 , 2020, Aging.

[7]  Jianpeng Han,et al.  Resveratrol promotes osteoblastic differentiation in a rat model of postmenopausal osteoporosis by regulating autophagy , 2020, Nutrition & Metabolism.

[8]  Yi Xiong,et al.  Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice. , 2020, Life sciences.

[9]  M. Unal.  LETTER TO THE EDITOR , 2020, Connective tissue research.

[10]  Qianqian Wang,et al.  The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  J. Nyman,et al.  Assessing matrix quality by Raman spectroscopy helps predict fracture toughness of human cortical bone , 2019, Scientific Reports.

[12]  J. Kalra,et al.  Resveratrol restores the level of key inflammatory cytokines and RANKL/OPG ratio in the femur of rat osteoporosis model , 2018, Journal of women & aging.

[13]  G. Mundy,et al.  The polyphenol resveratrol promotes skeletal growth in mice through a sirtuin 1‐bone morphogenic protein 2 longevity axis , 2018, British journal of pharmacology.

[14]  J. Nyman,et al.  Assessing glycation‐mediated changes in human cortical bone with Raman spectroscopy , 2018, Journal of biophotonics.

[15]  Wei Zhang,et al.  In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats , 2017, International journal of molecular medicine.

[16]  Xu-lei Tang,et al.  Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity , 2017, International journal of molecular medicine.

[17]  Liaobin Chen,et al.  Protective effects of resveratrol on osteoporosis via activation of the SIRT1-NF-κB signaling pathway in rats. , 2017, Experimental and therapeutic medicine.

[18]  K. Klaushofer,et al.  Vibrational spectroscopic techniques to assess bone quality , 2017, Osteoporosis International.

[19]  Jean X. Jiang,et al.  Coupling Effect of Water and Proteoglycans on the In Situ Toughness of Bone , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  O. Akkus,et al.  Novel Raman Spectroscopic Biomarkers Indicate That Postyield Damage Denatures Bone's Collagen , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[22]  S. Kook,et al.  Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. , 2016, Acta biomaterialia.

[23]  Ozan Akkus,et al.  Raman spectral classification of mineral- and collagen-bound water's associations to elastic and post-yield mechanical properties of cortical bone. , 2015, Bone.

[24]  Qiao-yan Zhang,et al.  Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. , 2015, The Journal of nutritional biochemistry.

[25]  J. Tou.  Resveratrol supplementation affects bone acquisition and osteoporosis: Pre-clinical evidence toward translational diet therapy. , 2015, Biochimica et biophysica acta.

[26]  R. Cabo,et al.  Resveratrol supplementation: Where are we now and where should we go? , 2015, Ageing Research Reviews.

[27]  Y. Yoshiko,et al.  The bioactive acidic serine- and aspartate-rich motif peptide. , 2015, Current protein & peptide science.

[28]  M. Morris,et al.  Contributions of Raman spectroscopy to the understanding of bone strength. , 2015, BoneKEy reports.

[29]  Z. Wang,et al.  Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway. , 2014, Acta biochimica et biophysica Sinica.

[30]  L. Nguyen,et al.  Effects of Resveratrol Supplementation on Bone Growth in Young Rats and Microarchitecture and Remodeling in Ageing Rats , 2014, Nutrients.

[31]  Yongwon Choi,et al.  Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond , 2014, Front. Immunol..

[32]  H. Komori,et al.  Dlx5 and Mef2 Regulate a Novel Runx2 Enhancer for Osteoblast‐Specific Expression , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  M. Sarıkanat,et al.  Sodium tungstate alleviates biomechanical properties of diabetic rat femur via modulation of oxidative stress. , 2014, General physiology and biophysics.

[34]  C. Ohlsson,et al.  Resveratrol Treatment Delays Growth Plate Fusion and Improves Bone Growth in Female Rabbits , 2013, PloS one.

[35]  J. Gigliotti,et al.  Resveratrol supplementation preserves long bone mass, microstructure, and strength in hindlimb-suspended old male rats , 2013, Journal of Bone and Mineral Metabolism.

[36]  N. Demir,et al.  Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs , 2012, Pharmacological reports : PR.

[37]  K. Hankenson,et al.  Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation , 2011, Journal of cellular biochemistry.

[38]  H. Hausenblas,et al.  Resveratrol and health--a comprehensive review of human clinical trials. , 2011, Molecular nutrition & food research.

[39]  V. Beral,et al.  Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy , 2011, Journal of the National Cancer Institute.

[40]  L. Bonewald,et al.  Identification of osteocyte‐selective proteins , 2010, Proteomics.

[41]  A. Hedge,et al.  Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. , 2009, Endocrinology.

[42]  Ming Zhao,et al.  3D QSAR of novel estrogen-RGD peptide conjugates: getting insight into structural dependence of anti-osteoporosis activity and side effect of estrogen in ERT. , 2009, Bioorganic & medicinal chemistry.

[43]  C. Cooper,et al.  Epidemiology of osteoporosis. , 2008, Best practice & research. Clinical endocrinology & metabolism.

[44]  A. Tosteson,et al.  Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  O. Erel,et al.  A new automated colorimetric method for measuring total oxidant status. , 2005, Clinical biochemistry.

[46]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[47]  C. Turner.  Biomechanics of Bone: Determinants of Skeletal Fragility and Bone Quality , 2002, Osteoporosis International.

[48]  O. Johnell,et al.  World-wide Projections for Hip Fracture , 1997, Osteoporosis International.